Peto’s paradox and human cancers

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 370, Issue 1673, 2015, Pages

  Noble, Robert ^a   Kaltz, Oliver ^a   Hochberg, Michael E ^a,b  

^a UNIV MONTPELLIER   (France)

^b SANTA FE INSTITUTE   (United States)

Author keywords

Cancer; Carcinogenesis; Disease; Peto s paradox; Stem cells; bad luck mutations

Indexed keywords

BODY SIZE; CANCER; CARCINOGEN; CELLS AND CELL COMPONENTS; DATA SET; EVOLUTIONARY BIOLOGY; HEALTH RISK; NATURAL SELECTION; OBSERVATIONAL METHOD;

ANIMALIA;

BIOLOGICAL MODEL; CELL COUNT; CELL PROLIFERATION; EVOLUTION; FEMALE; HUMAN; MALE; NEOPLASMS; ORGAN SIZE; PATHOLOGY; RISK FACTOR; STATISTICAL MODEL; STEM CELL;

BIOLOGICAL EVOLUTION; CELL COUNT; CELL PROLIFERATION; FEMALE; HUMANS; LINEAR MODELS; MALE; MODELS, BIOLOGICAL; NEOPLASMS; ORGAN SIZE; RISK FACTORS; STEM CELLS;

EID: 84930885527     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2015.0104     Document Type: Article

References (26)

1. Peto R. 1977 Epidemiology, multistage models, and short-term mutagenicity tests. Orig. Hum. Cancer 4, 1403–1428.
2. Leroi AM, Koufopanou V, Burt A. 2003 Cancer selection. Nat. Rev. Cancer 3, 226–231. (doi:10.1038/nrc1016).
3. Caulin AF, Maley CC. 2011 Peto’s paradox: evolution’s prescription for cancer prevention. Trends Ecol. Evol. 26, 175–182. (doi:10.1016/j.tree.2011.01.002).
4. Nunney L. 2013 The real war on cancer: the evolutionary dynamics of cancer suppression. Evol. Appl. 6, 11–19. (doi:10.1111/eva.12018).
5. Aktipis CA, Boddy AM, Jansen G, Hibner U, Hochberg ME, Maley CC, Wilkinson GS. 2015 Cancer across the tree of life: cooperation and cheating in multicellularity. Phil. Trans. R. Soc. B 370, 20140219. (doi:10.1098/rstb.2014.0219).
6. Nunney L. 1999 Lineage selection and the evolution of multistage carcinogenesis. Proc. R. Soc. Lond. B 266, 493–498. (doi:10.1098/rspb.1999.0664).
7. Boddy AM, Kokko H, Breden F, Wilkinson GS, Aktipis CA. 2015 Cancer susceptibility and reproductive trade-offs: a model of the evolution of cancer defences. Phil. Trans. R. Soc. B 370, 20140220. (doi:10.1098/rstb.2014.0220).
8. Kokko H, Hochberg ME. 2015 Towards cancer-aware life-history modelling. Phil. Trans. R. Soc. B 370, 20140234. (doi:10.1098/rstb.2014.0234).
9. Tomasetti C, Vogelstein B. 2015 Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 346, 78–81. (doi:10.1126/science.1260825).
10. Altenberg L. 2015 Statistical problems in a paper on variation in cancer risk among tissues, and new discoveries. (http://arxiv.org/abs/1501.04605).
11. Noble R, Kaltz O, Hochberg ME. 2015 Statistical interpretations and new findings on Variation in Cancer Risk Among Tissues. (http://arxiv.org/abs/1502.01061).
12. Tomasetti C, Vogelstein B. 2015 Musings on the theory that variation in cancer risk among tissues can be explained by the number of divisions of normal stem cells. (http://arxiv.org/abs/1501.05035).
13. R Core Team. 2013 R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
14. Wong CSM, Strange RC, Lear JT. 2003 Basal cell carcinoma. Br. Med. J. 327, 794–798. (doi:10.1136/bmj.327.7418.794).
15. Nunney L, Muir B. 2015 Peto’s paradox and the hallmarks of cancer: constructing an evolutionary framework for understanding the incidence of cancer. Phil. Trans. R. Soc. B 370, 20150161. (doi:10.1098/rstb.2015.0161).
16. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. 2000 International classification of diseases for oncology, 3rd edn. Geneva, Switzerland: World Health Organization.
17. Scotto J, Fears TR, Fraumeni JF et al. 1983 Incidence of nonmelanoma skin cancer in the United States. Washington, DC: US Department of Health and Human Services.
18. Roussel MF, Hatten ME. 2011 Cerebellum: development and medulloblastoma. Curr. Top. Dev. Biol. 94, 235–282. (doi:10.1016/B978-0-12-380916-2.00008-5).
19. Albanes D, Winick M. 1988 Are cell number and cell proliferation risk factors for cancer? J. Natl Cancer Inst. 80, 772–775. (doi:10.1093/jnci/80.10.772).
20. Roychoudhuri R, Putcha V, Møller H. 2006 Cancer and laterality: a study of the five major paired organs (UK). Cancer Causes Control 17, 655–662. (doi:10.1007/s10552-005-0615-9).
21. DeGregori J. 2013 Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age? Oncogene 32, 1869–1875. (doi:10.1038/onc.2012.281).
22. Cairns J. 2002 Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc. Natl Acad. Sci. USA 99, 10 567–10 570. (doi:10.1073/pnas.162369899).
23. Hochberg ME, Thomas F, Assenat E, Hibner U. 2013 Preventive evolutionary medicine of cancers. Evol. Appl. 6, 134–143. (doi:10.1111/eva.12033).
24. Roche B, Ujvari B, Thomas F. In press. Bad luck and cancer: does evolution spin the wheel of fortune? BioEssays 53. (doi:10.1002/bies.201500012).
25. Kabat GC et al. 2013 Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol. Biomark. Prev. 22, 1353–1363. (doi:10.1158/1055-9965.EPI-13-0305).
26. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V, Million Women Study collaborators. 2011 Height and cancer incidence in the million women study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 12, 785–794. (doi:10.1016/S1470-2045(11)70154-1).